• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problems Malposition of Device (2616); Device Dislodged or Dislocated (2923)
Patient Problem No Information (3190)
Event Date 10/05/2016
Event Type  Injury  
Event Description
The manufacturer was notified on 05-oct-2016 of the following: the first valve that was used has been reported as a separate event.(livanova case #(b)(4); 3004478276-2016-00133).The patient is a (b)(6) male who had been treated for endocarditis, having avr, mvp, cabg x3 using lima and right greater saphenous vein.Intra-op annulus was measured at 22mm and no stj measurement was taken to figure out a ratio.Three distal graft were performed before the valves.The surgeon open the left atrium and placed 28mm carbiomedics annuloflo ridge ring on the mitral then closed the left atrium.Next he opened the aorta to debride the leaflets and inspect the annulus.There were no abscesses or damage to the annulus from the endocarditis.He started sizing and felt that the large size valve was correct.Valve was prepared according to ifu with no problems while the surgeon placed the three guide sutures 2mm below the nadir.Valve was lowered and checked before deployed.Valve looked good and was balloon at 4atms for 30seconds with warm saline.Valve was inspected again after ballooning and no issues were seen.The aortotomy was closed and two proximals were done.Crossclamp was removed and heart de-aired.First look at echo the valve had migrated into the valsalva.The crossclamp was then reapplied and heart stopped to remove the valve.This report is for the second valve used: after resizing the valve the medium transparent end passed and the white passed with some force but not a lot.The medium valve was chosen since the large valve dislodge and the surgeon couldn't find a reason for it dislodging.The medium valve and accessories were opened and the valve prepared again with no issues and the guide sutures were placed again 2mm below the nadir.Valve was lowered and deployed.This time the after deployment surgeon noticed it was to high on the left sinus side and removed the valve to be prepared again.Using the same guide sutures the valve was lowered and deployed.This time the valve was at the correct depth with no annulus showing and deployed with no problems.The surgeon then ballooned the valve at 4atms for 30secs with warm saline.The blue collar was at the top of the leaflets and when the balloon was deflated the surgeon inspected the valve and saw the medium valve had pushed up on the left and non coronary sinus sides.Surgeon stated that the ring was pushing in on the aorto-mitral continuity and this is the reason.So the valve was removed and a 23mm solo valve was implanted.Total bypass time 212 minutes, total cross clamp time: 180 minutes, first cross clamp time: 105 minutes, second cross clamp time: 75minutes.
 
Manufacturer Narrative
Design history record review was completed on mar 29, 2017.The complete manufacturing and material records for the perceval heart valve, model icv1209, s/n (b)(4), were pulled and reviewed by quality control at livanova (b)(4) corp.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model icv1209) perceval heart valve at the time of manufacture and release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
4125650
MDR Report Key6079301
MDR Text Key59188744
Report Number3004478276-2016-00134
Device Sequence Number1
Product Code DYE
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)190315
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/04/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/15/2019
Device Model NumberPVS23
Device Catalogue NumberICV1209
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/29/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/15/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
Patient Weight97
-
-